nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—Vandetanib—thyroid cancer	0.537	1	CbGbCtD
Gatifloxacin—Pruritus—Vandetanib—thyroid cancer	0.00116	0.00251	CcSEcCtD
Gatifloxacin—Neck pain—Epirubicin—thyroid cancer	0.00116	0.00251	CcSEcCtD
Gatifloxacin—Thinking abnormal—Doxorubicin—thyroid cancer	0.00116	0.00251	CcSEcCtD
Gatifloxacin—Arthralgia—Sorafenib—thyroid cancer	0.00116	0.0025	CcSEcCtD
Gatifloxacin—Myalgia—Sorafenib—thyroid cancer	0.00116	0.0025	CcSEcCtD
Gatifloxacin—Glossitis—Doxorubicin—thyroid cancer	0.00115	0.00249	CcSEcCtD
Gatifloxacin—Lacrimation increased—Doxorubicin—thyroid cancer	0.00115	0.00249	CcSEcCtD
Gatifloxacin—Vaginal inflammation—Epirubicin—thyroid cancer	0.00115	0.00248	CcSEcCtD
Gatifloxacin—Injection site reaction—Epirubicin—thyroid cancer	0.00114	0.00247	CcSEcCtD
Gatifloxacin—Diarrhoea—Vandetanib—thyroid cancer	0.00113	0.00243	CcSEcCtD
Gatifloxacin—Bone pain—Doxorubicin—thyroid cancer	0.00111	0.0024	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00111	0.0024	CcSEcCtD
Gatifloxacin—Colitis—Epirubicin—thyroid cancer	0.0011	0.00238	CcSEcCtD
Gatifloxacin—Infection—Sorafenib—thyroid cancer	0.0011	0.00238	CcSEcCtD
Gatifloxacin—Candida infection—Epirubicin—thyroid cancer	0.0011	0.00237	CcSEcCtD
Gatifloxacin—Shock—Sorafenib—thyroid cancer	0.00109	0.00236	CcSEcCtD
Gatifloxacin—Fluid retention—Epirubicin—thyroid cancer	0.00109	0.00236	CcSEcCtD
Gatifloxacin—Dizziness—Vandetanib—thyroid cancer	0.00109	0.00235	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00109	0.00235	CcSEcCtD
Gatifloxacin—Vaginal infection—Epirubicin—thyroid cancer	0.00109	0.00234	CcSEcCtD
Gatifloxacin—Neck pain—Doxorubicin—thyroid cancer	0.00108	0.00232	CcSEcCtD
Gatifloxacin—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00106	0.0023	CcSEcCtD
Gatifloxacin—Dry eye—Epirubicin—thyroid cancer	0.00106	0.00229	CcSEcCtD
Gatifloxacin—Anorexia—Sorafenib—thyroid cancer	0.00106	0.00228	CcSEcCtD
Gatifloxacin—Injection site reaction—Doxorubicin—thyroid cancer	0.00106	0.00228	CcSEcCtD
Gatifloxacin—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00106	0.00228	CcSEcCtD
Gatifloxacin—Vomiting—Vandetanib—thyroid cancer	0.00105	0.00226	CcSEcCtD
Gatifloxacin—Rash maculo-papular—Epirubicin—thyroid cancer	0.00105	0.00226	CcSEcCtD
Gatifloxacin—Ecchymosis—Epirubicin—thyroid cancer	0.00104	0.00224	CcSEcCtD
Gatifloxacin—Mouth ulceration—Epirubicin—thyroid cancer	0.00104	0.00224	CcSEcCtD
Gatifloxacin—Rash—Vandetanib—thyroid cancer	0.00104	0.00224	CcSEcCtD
Gatifloxacin—Dermatitis—Vandetanib—thyroid cancer	0.00104	0.00224	CcSEcCtD
Gatifloxacin—Headache—Vandetanib—thyroid cancer	0.00103	0.00223	CcSEcCtD
Gatifloxacin—Colitis—Doxorubicin—thyroid cancer	0.00102	0.0022	CcSEcCtD
Gatifloxacin—Candida infection—Doxorubicin—thyroid cancer	0.00102	0.00219	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00101	0.00218	CcSEcCtD
Gatifloxacin—Fluid retention—Doxorubicin—thyroid cancer	0.00101	0.00218	CcSEcCtD
Gatifloxacin—Hypertonia—Epirubicin—thyroid cancer	0.00101	0.00218	CcSEcCtD
Gatifloxacin—Vaginal infection—Doxorubicin—thyroid cancer	0.001	0.00217	CcSEcCtD
Gatifloxacin—Abnormal vision—Epirubicin—thyroid cancer	0.001	0.00216	CcSEcCtD
Gatifloxacin—Mental disability—Epirubicin—thyroid cancer	0.000998	0.00215	CcSEcCtD
Gatifloxacin—Dyspnoea—Sorafenib—thyroid cancer	0.00099	0.00214	CcSEcCtD
Gatifloxacin—Dry eye—Doxorubicin—thyroid cancer	0.000983	0.00212	CcSEcCtD
Gatifloxacin—Lymphadenopathy—Epirubicin—thyroid cancer	0.000979	0.00211	CcSEcCtD
Gatifloxacin—Nausea—Vandetanib—thyroid cancer	0.000978	0.00211	CcSEcCtD
Gatifloxacin—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000978	0.00211	CcSEcCtD
Gatifloxacin—Dyspepsia—Sorafenib—thyroid cancer	0.000977	0.00211	CcSEcCtD
Gatifloxacin—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000967	0.00209	CcSEcCtD
Gatifloxacin—Decreased appetite—Sorafenib—thyroid cancer	0.000965	0.00208	CcSEcCtD
Gatifloxacin—Mouth ulceration—Doxorubicin—thyroid cancer	0.000962	0.00208	CcSEcCtD
Gatifloxacin—Ecchymosis—Doxorubicin—thyroid cancer	0.000962	0.00208	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Epirubicin—thyroid cancer	0.00096	0.00207	CcSEcCtD
Gatifloxacin—Photosensitivity—Epirubicin—thyroid cancer	0.000951	0.00205	CcSEcCtD
Gatifloxacin—Constipation—Sorafenib—thyroid cancer	0.000949	0.00205	CcSEcCtD
Gatifloxacin—Hypertonia—Doxorubicin—thyroid cancer	0.000933	0.00201	CcSEcCtD
Gatifloxacin—Abnormal vision—Doxorubicin—thyroid cancer	0.000928	0.002	CcSEcCtD
Gatifloxacin—Eye pain—Epirubicin—thyroid cancer	0.000925	0.002	CcSEcCtD
Gatifloxacin—Mental disability—Doxorubicin—thyroid cancer	0.000923	0.00199	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000908	0.00196	CcSEcCtD
Gatifloxacin—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000905	0.00195	CcSEcCtD
Gatifloxacin—Renal failure acute—Epirubicin—thyroid cancer	0.000904	0.00195	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000888	0.00192	CcSEcCtD
Gatifloxacin—Urticaria—Sorafenib—thyroid cancer	0.000882	0.0019	CcSEcCtD
Gatifloxacin—Photosensitivity—Doxorubicin—thyroid cancer	0.00088	0.0019	CcSEcCtD
Gatifloxacin—Abdominal pain—Sorafenib—thyroid cancer	0.000878	0.00189	CcSEcCtD
Gatifloxacin—Body temperature increased—Sorafenib—thyroid cancer	0.000878	0.00189	CcSEcCtD
Gatifloxacin—Renal impairment—Epirubicin—thyroid cancer	0.000877	0.00189	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Epirubicin—thyroid cancer	0.000874	0.00189	CcSEcCtD
Gatifloxacin—Eye pain—Doxorubicin—thyroid cancer	0.000856	0.00185	CcSEcCtD
Gatifloxacin—Hypoglycaemia—Epirubicin—thyroid cancer	0.000855	0.00185	CcSEcCtD
Gatifloxacin—Renal failure acute—Doxorubicin—thyroid cancer	0.000837	0.00181	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000835	0.0018	CcSEcCtD
Gatifloxacin—Migraine—Epirubicin—thyroid cancer	0.000822	0.00177	CcSEcCtD
Gatifloxacin—Hypersensitivity—Sorafenib—thyroid cancer	0.000818	0.00177	CcSEcCtD
Gatifloxacin—Renal impairment—Doxorubicin—thyroid cancer	0.000812	0.00175	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000808	0.00174	CcSEcCtD
Gatifloxacin—Face oedema—Epirubicin—thyroid cancer	0.000806	0.00174	CcSEcCtD
Gatifloxacin—Asthenia—Sorafenib—thyroid cancer	0.000797	0.00172	CcSEcCtD
Gatifloxacin—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000792	0.00171	CcSEcCtD
Gatifloxacin—Pruritus—Sorafenib—thyroid cancer	0.000786	0.0017	CcSEcCtD
Gatifloxacin—Ataxia—Epirubicin—thyroid cancer	0.000785	0.00169	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000772	0.00167	CcSEcCtD
Gatifloxacin—Dry skin—Epirubicin—thyroid cancer	0.000765	0.00165	CcSEcCtD
Gatifloxacin—Migraine—Doxorubicin—thyroid cancer	0.00076	0.00164	CcSEcCtD
Gatifloxacin—Diarrhoea—Sorafenib—thyroid cancer	0.00076	0.00164	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000747	0.00161	CcSEcCtD
Gatifloxacin—Face oedema—Doxorubicin—thyroid cancer	0.000746	0.00161	CcSEcCtD
Gatifloxacin—Gastritis—Epirubicin—thyroid cancer	0.000739	0.00159	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000736	0.00159	CcSEcCtD
Gatifloxacin—Muscular weakness—Epirubicin—thyroid cancer	0.000736	0.00159	CcSEcCtD
Gatifloxacin—Dizziness—Sorafenib—thyroid cancer	0.000734	0.00158	CcSEcCtD
Gatifloxacin—Ataxia—Doxorubicin—thyroid cancer	0.000726	0.00157	CcSEcCtD
Gatifloxacin—Dysphagia—Epirubicin—thyroid cancer	0.000722	0.00156	CcSEcCtD
Gatifloxacin—Asthma—Epirubicin—thyroid cancer	0.000722	0.00156	CcSEcCtD
Gatifloxacin—Dry skin—Doxorubicin—thyroid cancer	0.000708	0.00153	CcSEcCtD
Gatifloxacin—Pancreatitis—Epirubicin—thyroid cancer	0.000707	0.00153	CcSEcCtD
Gatifloxacin—Vomiting—Sorafenib—thyroid cancer	0.000706	0.00152	CcSEcCtD
Gatifloxacin—Rash—Sorafenib—thyroid cancer	0.0007	0.00151	CcSEcCtD
Gatifloxacin—Dermatitis—Sorafenib—thyroid cancer	0.000699	0.00151	CcSEcCtD
Gatifloxacin—Headache—Sorafenib—thyroid cancer	0.000696	0.0015	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000691	0.00149	CcSEcCtD
Gatifloxacin—Gastritis—Doxorubicin—thyroid cancer	0.000684	0.00148	CcSEcCtD
Gatifloxacin—Muscular weakness—Doxorubicin—thyroid cancer	0.000681	0.00147	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000681	0.00147	CcSEcCtD
Gatifloxacin—Neutropenia—Epirubicin—thyroid cancer	0.000675	0.00146	CcSEcCtD
Gatifloxacin—Dysuria—Epirubicin—thyroid cancer	0.000675	0.00146	CcSEcCtD
Gatifloxacin—Asthma—Doxorubicin—thyroid cancer	0.000668	0.00144	CcSEcCtD
Gatifloxacin—Dysphagia—Doxorubicin—thyroid cancer	0.000668	0.00144	CcSEcCtD
Gatifloxacin—Nausea—Sorafenib—thyroid cancer	0.00066	0.00142	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000659	0.00142	CcSEcCtD
Gatifloxacin—Pancreatitis—Doxorubicin—thyroid cancer	0.000655	0.00141	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Epirubicin—thyroid cancer	0.000651	0.0014	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000638	0.00138	CcSEcCtD
Gatifloxacin—Stomatitis—Epirubicin—thyroid cancer	0.000627	0.00135	CcSEcCtD
Gatifloxacin—Conjunctivitis—Epirubicin—thyroid cancer	0.000625	0.00135	CcSEcCtD
Gatifloxacin—Dysuria—Doxorubicin—thyroid cancer	0.000624	0.00135	CcSEcCtD
Gatifloxacin—Neutropenia—Doxorubicin—thyroid cancer	0.000624	0.00135	CcSEcCtD
Gatifloxacin—Sweating—Epirubicin—thyroid cancer	0.000617	0.00133	CcSEcCtD
Gatifloxacin—Haematuria—Epirubicin—thyroid cancer	0.000613	0.00132	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000609	0.00132	CcSEcCtD
Gatifloxacin—Epistaxis—Epirubicin—thyroid cancer	0.000607	0.00131	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000602	0.0013	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00059	0.00127	CcSEcCtD
Gatifloxacin—Bradycardia—Epirubicin—thyroid cancer	0.000588	0.00127	CcSEcCtD
Gatifloxacin—Stomatitis—Doxorubicin—thyroid cancer	0.00058	0.00125	CcSEcCtD
Gatifloxacin—Conjunctivitis—Doxorubicin—thyroid cancer	0.000579	0.00125	CcSEcCtD
Gatifloxacin—Hepatitis—Epirubicin—thyroid cancer	0.000578	0.00125	CcSEcCtD
Gatifloxacin—Pharyngitis—Epirubicin—thyroid cancer	0.000573	0.00124	CcSEcCtD
Gatifloxacin—Sweating—Doxorubicin—thyroid cancer	0.000571	0.00123	CcSEcCtD
Gatifloxacin—Oedema peripheral—Epirubicin—thyroid cancer	0.000569	0.00123	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—thyroid cancer	0.000568	0.00122	CcSEcCtD
Gatifloxacin—Epistaxis—Doxorubicin—thyroid cancer	0.000561	0.00121	CcSEcCtD
Gatifloxacin—Visual impairment—Epirubicin—thyroid cancer	0.000557	0.0012	CcSEcCtD
Gatifloxacin—Erythema multiforme—Epirubicin—thyroid cancer	0.000546	0.00118	CcSEcCtD
Gatifloxacin—Bradycardia—Doxorubicin—thyroid cancer	0.000544	0.00117	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—thyroid cancer	0.00054	0.00116	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—thyroid cancer	0.000538	0.00116	CcSEcCtD
Gatifloxacin—Hepatitis—Doxorubicin—thyroid cancer	0.000534	0.00115	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—thyroid cancer	0.00053	0.00114	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000526	0.00114	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—thyroid cancer	0.000518	0.00112	CcSEcCtD
Gatifloxacin—Visual impairment—Doxorubicin—thyroid cancer	0.000515	0.00111	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000505	0.00109	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—thyroid cancer	0.000503	0.00108	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—thyroid cancer	0.000499	0.00108	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—thyroid cancer	0.000498	0.00108	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—thyroid cancer	0.000495	0.00107	CcSEcCtD
Gatifloxacin—Tension—Epirubicin—thyroid cancer	0.000493	0.00106	CcSEcCtD
Gatifloxacin—Dysgeusia—Epirubicin—thyroid cancer	0.000492	0.00106	CcSEcCtD
Gatifloxacin—Nervousness—Epirubicin—thyroid cancer	0.000488	0.00105	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—thyroid cancer	0.000486	0.00105	CcSEcCtD
Gatifloxacin—Muscle spasms—Epirubicin—thyroid cancer	0.000483	0.00104	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—thyroid cancer	0.00048	0.00103	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—thyroid cancer	0.000474	0.00102	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—thyroid cancer	0.000465	0.001	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—thyroid cancer	0.000462	0.000997	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—thyroid cancer	0.000458	0.000989	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—thyroid cancer	0.000457	0.000985	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—thyroid cancer	0.000456	0.000983	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—thyroid cancer	0.000452	0.000975	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—thyroid cancer	0.000452	0.000975	CcSEcCtD
Gatifloxacin—Syncope—Epirubicin—thyroid cancer	0.000451	0.000973	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—thyroid cancer	0.00045	0.000971	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—thyroid cancer	0.000447	0.000965	CcSEcCtD
Gatifloxacin—Palpitations—Epirubicin—thyroid cancer	0.000444	0.000959	CcSEcCtD
Gatifloxacin—Loss of consciousness—Epirubicin—thyroid cancer	0.000442	0.000954	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—thyroid cancer	0.000438	0.000946	CcSEcCtD
Gatifloxacin—Convulsion—Epirubicin—thyroid cancer	0.000436	0.00094	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—thyroid cancer	0.000434	0.000937	CcSEcCtD
Gatifloxacin—Chest pain—Epirubicin—thyroid cancer	0.000428	0.000924	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—thyroid cancer	0.000428	0.000924	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—thyroid cancer	0.000428	0.000924	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—thyroid cancer	0.000428	0.000923	CcSEcCtD
Gatifloxacin—Anxiety—Epirubicin—thyroid cancer	0.000427	0.000921	CcSEcCtD
Gatifloxacin—Vertigo—Doxorubicin—thyroid cancer	0.000418	0.000902	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—thyroid cancer	0.000417	0.0009	CcSEcCtD
Gatifloxacin—Confusional state—Epirubicin—thyroid cancer	0.000414	0.000893	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—thyroid cancer	0.000411	0.000887	CcSEcCtD
Gatifloxacin—Oedema—Epirubicin—thyroid cancer	0.00041	0.000885	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—thyroid cancer	0.00041	0.000885	CcSEcCtD
Gatifloxacin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000409	0.000882	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—thyroid cancer	0.000408	0.00088	CcSEcCtD
Gatifloxacin—Shock—Epirubicin—thyroid cancer	0.000404	0.000871	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—thyroid cancer	0.000403	0.00087	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000402	0.000867	CcSEcCtD
Gatifloxacin—Hypertension—Doxorubicin—thyroid cancer	0.000402	0.000867	CcSEcCtD
Gatifloxacin—Tachycardia—Epirubicin—thyroid cancer	0.0004	0.000864	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000397	0.000856	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—thyroid cancer	0.000396	0.000855	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—thyroid cancer	0.000396	0.000855	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—thyroid cancer	0.000396	0.000855	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—thyroid cancer	0.000395	0.000852	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—thyroid cancer	0.000391	0.000844	CcSEcCtD
Gatifloxacin—Hypotension—Epirubicin—thyroid cancer	0.000383	0.000827	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—thyroid cancer	0.000383	0.000826	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—thyroid cancer	0.00038	0.000819	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00038	0.000819	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—thyroid cancer	0.000377	0.000814	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000374	0.000807	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—thyroid cancer	0.000374	0.000806	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000372	0.000802	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—thyroid cancer	0.000371	0.000801	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—thyroid cancer	0.000371	0.0008	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—thyroid cancer	0.000368	0.000795	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000367	0.000792	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—thyroid cancer	0.000366	0.000789	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—thyroid cancer	0.000365	0.000787	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—thyroid cancer	0.000362	0.000781	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—thyroid cancer	0.000361	0.000779	CcSEcCtD
Gatifloxacin—Decreased appetite—Epirubicin—thyroid cancer	0.000357	0.00077	CcSEcCtD
Gatifloxacin—Hypotension—Doxorubicin—thyroid cancer	0.000355	0.000766	CcSEcCtD
Gatifloxacin—Constipation—Epirubicin—thyroid cancer	0.000351	0.000757	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000346	0.000746	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—thyroid cancer	0.000343	0.000741	CcSEcCtD
Gatifloxacin—Paraesthesia—Doxorubicin—thyroid cancer	0.000341	0.000736	CcSEcCtD
Gatifloxacin—Dyspnoea—Doxorubicin—thyroid cancer	0.000338	0.00073	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—thyroid cancer	0.000338	0.00073	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—thyroid cancer	0.000338	0.000728	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000336	0.000724	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—thyroid cancer	0.000334	0.000721	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—thyroid cancer	0.00033	0.000712	CcSEcCtD
Gatifloxacin—Urticaria—Epirubicin—thyroid cancer	0.000326	0.000703	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—thyroid cancer	0.000325	0.000701	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—thyroid cancer	0.000324	0.0007	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—thyroid cancer	0.000324	0.0007	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000313	0.000675	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00031	0.00067	CcSEcCtD
Gatifloxacin—Hypersensitivity—Epirubicin—thyroid cancer	0.000302	0.000652	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—thyroid cancer	0.000302	0.000651	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—thyroid cancer	0.0003	0.000648	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—thyroid cancer	0.0003	0.000648	CcSEcCtD
Gatifloxacin—Asthenia—Epirubicin—thyroid cancer	0.000294	0.000635	CcSEcCtD
Gatifloxacin—Pruritus—Epirubicin—thyroid cancer	0.00029	0.000626	CcSEcCtD
Gatifloxacin—Diarrhoea—Epirubicin—thyroid cancer	0.000281	0.000606	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—thyroid cancer	0.00028	0.000604	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—thyroid cancer	0.000272	0.000588	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—thyroid cancer	0.000271	0.000586	CcSEcCtD
Gatifloxacin—Pruritus—Doxorubicin—thyroid cancer	0.000269	0.00058	CcSEcCtD
Gatifloxacin—Vomiting—Epirubicin—thyroid cancer	0.000261	0.000563	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—thyroid cancer	0.00026	0.000561	CcSEcCtD
Gatifloxacin—Rash—Epirubicin—thyroid cancer	0.000259	0.000558	CcSEcCtD
Gatifloxacin—Dermatitis—Epirubicin—thyroid cancer	0.000258	0.000558	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—thyroid cancer	0.000257	0.000555	CcSEcCtD
Gatifloxacin—Dizziness—Doxorubicin—thyroid cancer	0.000251	0.000542	CcSEcCtD
Gatifloxacin—Nausea—Epirubicin—thyroid cancer	0.000244	0.000526	CcSEcCtD
Gatifloxacin—Vomiting—Doxorubicin—thyroid cancer	0.000241	0.000521	CcSEcCtD
Gatifloxacin—Rash—Doxorubicin—thyroid cancer	0.000239	0.000517	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—thyroid cancer	0.000239	0.000516	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—thyroid cancer	0.000238	0.000513	CcSEcCtD
Gatifloxacin—Nausea—Doxorubicin—thyroid cancer	0.000226	0.000487	CcSEcCtD
